CBART: The Reduction of Psychological and Physiological Stress in Women Undergoing IVF
1 other identifier
interventional
88
1 country
1
Brief Summary
The study is a randomized controlled trial of a cognitive behavioral interventions and an art-based stress reduction treatment protocol (CB-ART) with 100 women, identified with elevated perceived stress, before undergoing IVF treatment; in order to examine its effect on perceived stress, plasma CFD, telomere length and pregnancy rates. CB-ART is a 6-session treatment protocol that has been utilized with women coping with stress, depression and pain and is effective in reducing these indicators, developed and evaluated by our research team. The treatment protocol emphasizes processing together with the client's recalled image, symptom or memory (ISM) pertaining to a current distressing mental or physical state. CB-ART is a multi-method model that integrates cognitive behavioral interventions and art-based stress reduction interventions. The innovation in this method is the transformation of imagined and drawn images and memories rather than solely verbally discussing their contents. The focus is on changing compositional elements that comprise each image and memory, thus providing a therapeutic venue to reframe and transform stress producing, recalled images and memories and reduce symptoms of perceived stress. Art making is beneficial for eliciting an emotional response and provides a concrete platform to conduct the cognitive processing that initiate change on the paper and then in the mind. Furthermore, the soothing qualities of interacting with art making foster and enhance behavioral relaxation techniques. Our study population, women with infertility problems, who are designated to undergo IVF treatment and have been identified to have elevated perceived stress scores on the Perceived Stress Scale (above 15) will be randomized and allocated to receive the CB-ART intervention tailored to reduce stress or treatment as usual.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2018
CompletedFirst Posted
Study publicly available on registry
March 8, 2018
CompletedStudy Start
First participant enrolled
April 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedSeptember 29, 2021
September 1, 2021
2 years
March 2, 2018
September 28, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Perceived Stress
The perceived stress scale (Cohen, Kamarck \& Mermelstein, 1994) is a 10 item scale measuring perceived stress by asking 10 questions in which participants are requested to list on a scale from 0- never to 4- very frequently, how often they have experienced different stress related occurrences in the past month. The scale is calculated by summing the items (4 items reversed) with scores ranging from 0 - 40. Higher scores indicate higher perceived stress, with the mean US score being 16.
2 months
Secondary Outcomes (3)
Cell Free DNA
2 months
Telomerase
2 months
Pregnancy
2 months
Study Arms (2)
CBART
EXPERIMENTAL6 weeks participation in CBART protocol before beginning IVF treatment
Wait control
NO INTERVENTIONParticipants will receive treatment as usual and will be able to receive the intervention after the study is complete.
Interventions
Cognitive Behavioral protocol that uses art-making for stress reduction and cognitive interventions
Eligibility Criteria
You may qualify if:
- Hebrew speaking nulliparous women
- between the ages of 18-35
- without an axis I psychiatric diagnosis
You may not qualify if:
- Women over 35
- Do not speak Hebrew
- Have an Axis I psychiatric diagnosis that would prevent them from participating in the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Haifalead
- Soroka University Medical Centercollaborator
- Ben-Gurion University of the Negevcollaborator
- Fondation de Myriam de Senarclenscollaborator
Study Sites (1)
Soroka University Medical Center
Beersheba, Israel
Related Publications (4)
Czamanski-Cohen J, Sarid O, Cwikel J, Levitas E, Lunenfeld E, Douvdevani A, Har-Vardi I. Decrease in cell free DNA levels following participation in stress reduction techniques among women undergoing infertility treatment. Arch Womens Ment Health. 2014 Jun;17(3):251-3. doi: 10.1007/s00737-013-0407-2. Epub 2014 Jan 14.
PMID: 24420416BACKGROUNDCzamanski-Cohen J, Sarid O, Cwikel J, Lunenfeld E, Douvdevani A, Levitas E, Har-Vardi I. Increased plasma cell-free DNA is associated with low pregnancy rates among women undergoing IVF-embryo transfer. Reprod Biomed Online. 2013 Jan;26(1):36-41. doi: 10.1016/j.rbmo.2012.09.018. Epub 2012 Oct 4.
PMID: 23182744BACKGROUNDCzamanski-Cohen J, Sarid O, Cwikel J, Douvdevani A, Levitas E, Lunenfeld E, Har-Vardi I. Cell-free DNA and telomere length among women undergoing in vitro fertilization treatment. J Assist Reprod Genet. 2015 Nov;32(11):1697-703. doi: 10.1007/s10815-015-0581-4. Epub 2015 Oct 5.
PMID: 26438644BACKGROUNDSarid O, Cwikel J, Czamanski-Cohen J, Huss E. Treating women with perinatal mood and anxiety disorders (PMADs) with a hybrid cognitive behavioural and art therapy treatment (CB-ART). Arch Womens Ment Health. 2017 Feb;20(1):229-231. doi: 10.1007/s00737-016-0668-7. Epub 2016 Sep 19.
PMID: 27645306BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iris Harvardi, PhD
Soroka University Medical Center
- PRINCIPAL INVESTIGATOR
Julie Cwikel, PhD
Ben-Gurion University of the Negev
- PRINCIPAL INVESTIGATOR
Orly Sarid
Ben-Gurion University of the Negev
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Research coordinator will conduct the randomization and all information will be deidentified. Investigator will not know who is in which group.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
March 2, 2018
First Posted
March 8, 2018
Study Start
April 16, 2019
Primary Completion
April 20, 2021
Study Completion
August 1, 2021
Last Updated
September 29, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share